在可卡因引起的肝衰竭中使用N-乙半氨酸:一个案例报告
Vanessa Biering1, Ronan Bellouard1,2, Maëlle Martin3
1Laboratoire de Pharmacologie Clinique, Centre Hospitalo-Universitaire (CHU) Nantes, Nantes, France.
Frontiers in toxicology
|January 30, 2025
概括
可卡因中毒可以导致严重的急性肝炎,这是一个罕见但严重的疾病. 这一案例表明N-乙半氨酸 (NAC) 可能改善有毒肝炎的肝功能,需要进一步调查.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 内部医学 内部医学
背景情况:
- 滥用可卡因是一个全球性的健康问题,有可能导致严重的医疗并发症.
- 急性肝炎是可卡因中毒的罕见但关键并发症,可能导致肝功能衰竭.
- 目前毒性肝炎的管理重点是支持性护理和并发症预防.
研究的目的:
- 报告可卡因中毒后出现的急性肝炎病例.
- 评估N-乙半氨酸 (NAC) 在可卡因诱导的有毒肝炎中的潜在治疗作用.
- 在治疗期间监测可卡因代谢物和临床化学.
主要方法:
- 一个28岁的女性患有可卡因中毒的案例介绍.
- 治疗包括N-乙囊 (NAC),透析和支持性护理.
- 监测肝酶,代谢酸症,功能和狂犬病溶解.
主要成果:
- 这位患者出现了急性肝炎,代谢性酸症,功能衰竭和狂犬病.
- 肝功能有所改善,在NAC给药后,转氨酶水平降低.
- 在整个临床过程中,对可卡因代谢物的毒动力学进行了监测.
结论:
- N-乙半氨酸 (NAC) 可能在治疗可卡因引起的急性毒性肝炎方面具有有益作用.
- 需要进一步的研究来确定NAC在非乙氨基毒性肝炎中的有效性.
- 这一案例凸显了可卡因中毒的多方面的系统性影响.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
779
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
779
Prevention of Further Absorption of Poison
777
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
777
Phase II Reactions: Acetylation Reactions
172
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
172


